Caffaro, Arthur Massabki; Lourenço, Felipe Rebello 
Fonte: Chemometrics and Intelligent Laboratory Systems. Unidade: FCF
Assunto: FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAFFARO, Arthur Massabki e LOURENÇO, Felipe Rebello. Total combined global risk assessment applied to pharmaceutical equivalence –a case study of ofloxacin medicines. Chemometrics and Intelligent Laboratory Systems, v. 241, p. 1-9 art. 104935, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.chemolab.2023.104935. Acesso em: 08 out. 2025.APA
Caffaro, A. M., & Lourenço, F. R. (2023). Total combined global risk assessment applied to pharmaceutical equivalence –a case study of ofloxacin medicines. Chemometrics and Intelligent Laboratory Systems, 241, 1-9 art. 104935. doi:10.1016/j.chemolab.2023.104935NLM
Caffaro AM, Lourenço FR. Total combined global risk assessment applied to pharmaceutical equivalence –a case study of ofloxacin medicines [Internet]. Chemometrics and Intelligent Laboratory Systems. 2023 ; 241 1-9 art. 104935.[citado 2025 out. 08 ] Available from: https://doi.org/10.1016/j.chemolab.2023.104935Vancouver
Caffaro AM, Lourenço FR. Total combined global risk assessment applied to pharmaceutical equivalence –a case study of ofloxacin medicines [Internet]. Chemometrics and Intelligent Laboratory Systems. 2023 ; 241 1-9 art. 104935.[citado 2025 out. 08 ] Available from: https://doi.org/10.1016/j.chemolab.2023.104935
